| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Generate Biomedicines, Inc. | President & CFO | Stock Option (Right to Buy) | 274,493 | 26 Feb 2026 | Direct | ||
| Generate Biomedicines, Inc. | President & CFO | Common Stock | 1,000 | 02 Mar 2026 | By son | ||
| Generate Biomedicines, Inc. | President & CFO | Common Stock | 500 | 02 Mar 2026 | By daughter |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GENB | Generate Biomedicines, Inc. | 26 Feb 2026 | 5 | +$32,000 | 4 | President & CFO | 02 Mar 2026, 17:54 |
| GENB | Generate Biomedicines, Inc. | 26 Feb 2026 | 0 | $0 | 3 | President & CFO | 26 Feb 2026, 20:50 |